Alzheimer’s disease therapy is undergoing a groundbreaking transformation with the integration of innovative immune strategies traditionally used in cancer treatment.Recent studies have revealed that targeting the TIM-3 molecule can effectively enhance cognitive improvement by empowering microglial cells in the brain to combat amyloid plaques associated with dementia.